Globavir Biosciences

Globavir Biosciences

A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.

Edit ID  18517931 

Dawson Sewell
Dawson Sewell edited on 25 Jun, 2020
Edits made to:
Infobox (+8 properties)
Timeline (+1 events) (+299 characters)
Description (+109 characters)
Article (+1273 characters)
Topic thumbnail

Globavir Biosciences

A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.

Article

Globavir Biosciences is a biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease that is headquartered in Los Altos, California and was founded in 2011 by Shalabh Gupta and Vijay Pande. The company is focused on commercializing re-purposed drugs for controlling infectious diseases such as coronavirus, dengue fever, ebola, and Chikungunya. Their lead drug candidate is called GBV-006 and is a combination of two drugs approved by the FDA for affecting viral load and mortality of viral infections.

Partnerships
Bio-Rad Laboratories

On October 17, 2016 Globavir Biosciences announced entering a partnership with Bio-Rad Laboratories to licence Globavir's PanGlob Dengue detection technology. There were no financial details of the partnership and licensing agreement between the two companies.

Funding
Seed

On November 12, 2012 Globavir Biosciences announced raising $2 million in seed funding from undisclosed investors.

Venture

On January 21, 2015 Globavir Biosciences announced raising $4 million in venture funding from StartX, Stanford University Venture Fund, and Sorrento Therapeutics.

Venture

On September 20, 2016 Globavir Biosciences announced raising $1.5 million in venture funding from undisclosed investors.

Infobox
Email address
info@globavir.com
Founded date
2011
Full address
5150 EL CAMINO REAL, Los Altos, California 94022, US
Phone number
+116503514495
Timeline

October 17, 2016

Partnership with Bio-Rad Laboratories

On October 17, 2016 Globavir Biosciences announced entering a partnership with Bio-Rad Laboratories to licence Globavir's PanGlob Dengue detection technology. There were no financial details of the partnership and licensing agreement between the two companies.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.